(Press-News.org) Experts in infection prevention and control at the Mount Sinai Health will present new research and insights at ID Week, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists in Los Angeles from October 16-19.
Mount Sinai doctors and researchers are also available for comment on breaking health news including the flu, COVID variants, HIV/AIDS, mpox, West Nile virus, measles, and fall vaccinations.
PRESENTATIONS and POSTER SESSIONS
*All abstracts and presentations are under embargo until the start of the meeting on Wednesday, October 16 at 12:01 a.m. Pacific time/3:01 a.m. Eastern time*
Wednesday, October 16, 2024
7:00-9:00 a.m. PT/10:00 a.m.-12:00 p.m. ET
Comprehensive Care for People With HIV: Navigating Comorbidities and Polypharmacy affiliated event
Location: Gold Ballroom 1-2 (live stream)
Speaker: Michelle S. Cespedes, MD, MS, Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai
Summary: The substantial burden of multimorbidity and polypharmacy among people with HIV complicates treatment decision-making to support lifelong wellness. This interactive symposium will discuss complex cases and reflect on real-world experiences. It will include expert-led guidance through treatment decisions for people with HIV facing common comorbid conditions; case-based application of the latest data and guideline recommendations; and real-world testimonials from people with HIV sharing their lived experiences and challenges managing comorbidities.
8:00 a.m.-12:00 p.m. PT/11:00 a.m.-3:00 p.m. ET
Premeeting Workshop
PW09 - Pus, Slough and Drainage: Oh My! Hands-On Introduction to Wound Care for the ID Clinician
Location: 502 B
Moderator: Madhavi Ponnapalli, MD, Associate Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai
Summary: This session will explain the benefit of debridement, and commonly used instruments for debridement in wound care. It will identify different modalities for offloading foot wounds; describe the rationale for the use of different wound dressings on different types of wounds; identify different types of compression wraps and stockings that may benefit a particular patient the most; describe the benefits of negative pressure wound therapy; and describe the caloric, protein, and mineral needs of a patient with a large decubitus wound.
Thursday, October 17, 2024
8:00-8:20 a.m. PT/11:00-11:20 a.m. ET
Session: Bills, Bill, Bills (and ID): What’s New and Exciting in Billing and Coding
40 - Case based discussion on optimizing billing and coding to impact reimbursement and quality metrics
Location: 404 AB
Presenter: Timothy Sullivan, MD, Associate Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai
Summary: The session will focus on strategies to improve billing and coding practices for infectious diseases physicians, with the ultimate goal of improving infectious diseases administration and sustaining this specialty.
2:15-2:30 p.m. PT/5:15-2:30 p.m. ET
Session: Beyond the Virus: HIV Therapy and Co-Morbidities Research
156 - A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in Patients with HIV
Location: 404 AB
Presenter: Melissa Margolis, MD, MSc, Resident Physician, Mount Sinai Hospital
Abstract: Hepatitis B (HBV) infection, relapse, or reactivation risk may be overlooked by clinicians when switching to two-drug regimens (2DR) for HIV. In this pilot Quality Improvement study, a simple Electronic Health Record-based intervention increased HBV screening prior to switch and decreased switches in those at highest risk of HBV reactivation (sAg+ or isolated cAb+), preventing HBV associated morbidity.
2:15-2:30 p.m. PT/5:15-2:30 p.m. ET
Session: Infections in Transplant and Hematologic Malignancy Patients, Part 1
161 - Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis
Location: Location: 408 A
Presenter: Emily Baneman, MD, Assistant Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai
Abstract: This is a prospective single-center observational study of Cytomegalovirus (CMV) reactivation among CMV seropositive adults undergoing treatment for multiple myeloma with anti-CD38 and anti-BCMA therapies including bispecific antibodies and CAR-T. The researchers share their findings in this interim analysis of the first 22 enrolled participants.
Saturday, October 19, 2024
8:00-8:30 a.m. PT/ 11:00-11:30 a.m. ET
Session: Challenging Cases in Patient Safety
453 - Risk Reduction: Screening for Latent Infections Before Immunosuppression/Vaccination
Location: 408 A
Presenter: Risa Fuller, MD, Assistant Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai
Summary: This session will cover patient safety and prevention of infection in immunocompromised hosts. Experts will share how to describe indications and timing of vaccinations in relation to immunosuppressive therapy; and how to know which latent infections need to be screened before immunosuppressive therapy initiation.
12:15-12:45 p.m. PT/3:15-3:45 p.m. ET
Session: Rapid Fire Cases
530 - Neonatal Meningitis: Difficult Microbial Identification and Severe Sequelae
Location: Halls JK - Arena 4
Presenter: Brian Gu, Pediatric Infectious Diseases Fellow at the Icahn School of Medicine at Mount Sinai
Summary: This case report describes a 1-month-old infant who presented with meningitis and development of multiple large brain abscesses caused by an infection with Paenibacillus dendritiformis. In addition to medical management, multiple neurosurgical interventions were required to manage this infection. This case underscores a few important aspects of invasive Paenibacillus CNS infections, which are rarely reported in the literature.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report’s® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END
Mount Sinai Doctors to present at ID Week 2024
2024-10-16
ELSE PRESS RELEASES FROM THIS DATE:
Rewriting the future: New molecules reversibly change with light and heat
2024-10-16
In this age of cloud storage, few people are backing up data on CD-RWs. The technology to rewrite data on compact discs was made possible by phase-change materials altered by the light and heat of lasers, though this had a limit of 1,000 rewrites. Today, scientists investigating photoswitching molecules, which change their properties when irradiated, have been finding possible applications for these materials, ranging from photopharmacology to data storage.
Osaka Metropolitan University Graduate School of Engineering student Shota Hamatani, Dr. Daichi Kitagawa, a lecturer, and Professor Seiya Kobatake synthesized aza-diarylethenes, which have nitrogen in place of carbon in a molecular structure ...
New breakthrough in quantum computing development, hybrid quantum error correction technology
2024-10-16
A major challenge in realizing quantum computers is the development of 'quantum error correction' technology. This technology offers a solution for addressing errors that occur in the qubit, the basic unit of quantum computation, and prevents them from being amplified during the computation. Without quantum error correction, it would be impossible for quantum computers to outperform classical counterparts, and thus efforts to advance this technology are ongoing worldwide.
Dr. Seung-Woo Lee's research team at the Korea ...
Unlocking the future: Information processing at the speed of light
2024-10-16
The integration of photonics into quantum computing has profound implications across various domains. As the demand for faster and more secure computational capabilities intensifies, photonic quantum computing emerges as a pivotal force, with the photonics market projected to reach USD 837.8 billion by 2025.
Harnessing the unique properties of light, photonic quantum computing revolutionizes data processing by encoding information in photons, offering unprecedented speed and efficiency for solving complex problems that traditional methods struggle to address. Photonic quantum computers can ...
A new chapter in cancer treatment: Innovative strategies and technologies of miRNA
2024-10-16
This study is led by Dr. Shiwei Duan (Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China). His team analyzed literature on miRNA, summarizing the close relationship between these small molecules and cancer. miRNA is a type of non-coding RNA that does not encode proteins, but can target more than 60% of human protein-coding genes. They play crucial roles in cell growth, differentiation, development, and apoptosis, and their dysfunction is closely linked to numerous diseases. Almost all known cancer cells have the ability to control gene expression using miRNAs, making the impact of miRNAs particularly significant ...
Silicon metasurfaces unlock broad-spectrum infrared imaging.
2024-10-16
Infrared imaging technology is crucial for advancing our understanding of the world, from exploring biological specimens to inspecting complex materials and detecting hidden patterns in physical systems. Infrared light can penetrate fog and smoke, making it invaluable for search and rescue, firefighting, and sensitive operations. Additionally, infrared imaging can enable visualising the heat emitted by objects, making it a powerful tool for night vision and security applications. While infrared cameras are valuable tools for enhanced ...
New research suggests: To get patients to accept medical AI, remind them of human biases
2024-10-16
While people are growing more accustomed to AI-driven personal assistants, customer service chatbots and even financial advisors, when it comes to healthcare, most still want it with a human touch.
Given that receiving healthcare is a deeply personal experience, it’s understandable that patients prefer it to come from, well, a person. But with AI’s vast potential to increase the quality, efficacy and efficiency of medicine, a push toward greater acceptance of artificial intelligence-driven medicine could unlock benefits ...
OIST and Partisia sign MOU to advance the research and development of multi-party computation and privacy enhancing technologies
2024-10-16
The Okinawa Institute of Science and Technology (OIST) and the Danish software company Partisia have signed a Memorandum of Understanding (MOU) to strengthen their research ties.
The primary objective of this collaboration is to advance research in Multi-Party Computation (MPC), focusing on developing innovative Privacy-Enhancing Technology solutions. By leveraging their combined knowledge and expertise, OIST and Partisia aim to deliver a global perspective on secure computation, quantum-safe cryptography, and cyber security.
OIST will contribute to the collaboration with its in-house expertise and ...
Beware of the full moon: Tropical forest mammals shy away from the moonlight
2024-10-16
A recent study using automatic wildlife cameras across three continents has shed light on how the moon's phases affect the behaviour of tropical forest mammals. Half of the species studied altered their activity levels or timing, or both, in response to the full moon. The findings suggest that even in some of the darkest places on earth - the floors of tropical forests - the moon's phases can influence animal behaviour. This impact could be even more pronounced in degraded and fragmented forests.
“Imagine playing hide-and-seek in a dark room, and then somebody lights ...
Energy-thirsty indoor vertical gardens ripe for improvement
2024-10-16
Indoor vertical gardens are gaining popularity among homeowners and restaurants, allowing them to grow microgreens year-round, but new research has identified a major drawback: their demands on energy.
A study by researchers from the Marche Polytechnic University and University of South Australia shows that while domestic vertical garden appliances can provide fresh, local produce under controlled conditions and with zero food miles, they do chew up energy.
Artificial lighting – essential for plant growth – accounted for more than 50% of the total energy costs in growing a crop of red lettuce, which is five times higher than professional ...
Around 40% of postmenopausal hormone positive breast cancers linked to excess body fat
2024-10-15
Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in the Journal of Epidemiology & Community Health.
This proportion is significantly higher than 1 in 10 such cases currently attributed to excess weight, using the widely used measure of body mass index (BMI), and indicates that the real impact of obesity on breast cancer risk has likely been underestimated, say the researchers.
BMI isn’t necessarily a very accurate measure of body fat, particularly in older women, because it doesn’t account for age, sex, or ethnicity, they point out.
They therefore ...